Article

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma

2026-01-30

Abstract excerpt

The standard treatment for stage I lung adenocarcinoma is surgical resection, in most cases without additional systemic adjuvant treatment. A significant proportion of stage I cases recur with a less than 50% 5-year survival rate. There are clinical data suggesting that adjuvant treatment may improve survival in such recurrent cases. However, previously evaluated predictors such as the IASLC grading system from hi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2f4e6050-2267-5d34-b269-9872401a2bc5
DOI: 10.64898/2026.01.28.26344973

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinomaDOI 10.64898/2026.01.28.26344973Read

An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study.Semantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

Learning the Language of Histopathology Images reveals Prognostic Subgroups in Invasive Lung Adenocarcinoma PatientsSemantic proximity Read

A Multimodal Neural Network Model for Early Recurrence Prediction in Lung AdenocarcinomaSemantic proximity Read

RADAR CARE Study: A Multicenter Deep Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer Using a Multimodal ApproachSemantic proximity Read

Independent prognostic value of a 4-gene transcriptomic signature in lung adenocarcinoma across five external cohortsSemantic proximity Read

IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretabilitySemantic proximity Read

A gene expression‐based single sample predictor of lung adenocarcinoma molecular subtype and prognosisSemantic proximity Read

Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent DiseaseSemantic proximity Read

Genomic signature driving preinvasive to invasive processes in stage I lung adenocarcinoma.Semantic proximity Read

Integration of a Molecular Prognostic Classifier into the Ninth Edition TNM Staging of Lung AdenocarcinomaSemantic proximity Read

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung CancerSemantic proximity Read